Adham El-Khalil gives an overview of Eurofind Participation. Since its creation in 1972, the group has been acting in different markets such as steel, PVC, food, beverages… In Africa, Eurofind is present in countries such as Côte d’Ivoire, Togo, Benin, Mali, Senegal, Nigeria and Cameroon.
Ibrahim Diawara est pharmacien de formation. Depuis Octobre 2006, il est le Président-Directeur Général de Cipharm, un groupe oeuvrant dans le secteur de l’industrie pharmaceutique en Côte d’Ivoire.
Jérémie N’Gouan, Head of Pigier Côte d’Ivoire, mentions some of the challenges to be faced by the institution.
Jérémie N’Gouan, Head of Pigier Côte d’Ivoire, mentions some partnership opportunities and shares his goals for the coming years.
Jérémie N’Gouan, Head of Pigier Côte d’Ivoire, explains what are the main advantages and differentials of the institution, mentioning the importance of maintaining high quality education.
Jérémie N’Gouan, Head of Pigier Côte d’Ivoire, gives his evaluation of the higher education system in Côte d’Ivoire, saying that in the last few years, the private sector has become increasingly important.
Profil de Cipharm, une entreprise ivoirienne devenue le fabriquant numéro 1 de produits pharmaceutiques en Côte d’Ivoire depuis sa création en 1988.
La Société Ivoirienne de Manutention et de Transit (SIMAT) entend passer de prestataire en manutention et logistique à leader dans la chaine d’approvisionnement grâce à un partenariat avec NileDutch, la ligne maritime Néerlandaise.
Stéphane Eholie, Chief Executive Officer of SIMAT (Société Ivoirienne de Manutention et de Transit)
Stéphane Eholie gives an evaluation of the logistics sector, mentioning the competition, SIMAT’s differentials, the areas to be developped and the importance of quality and social responsibility. Mr Eholie also shares his vision for the future of Côte d’Ivoire in the coming years.
Ibrahim Diawara, President and CEO of Cipharm, explains why a foreign investor interested in coming to Côte d’Ivoire should invest within the company. Mr Diawara also shares his vision for Cipharm in the coming years.
